HEADER SIGNALING PROTEIN 30-JAN-17 5UNG TITLE XFEL STRUCTURE OF HUMAN ANGIOTENSIN II TYPE 2 RECEPTOR (ORTHORHOMBIC TITLE 2 FORM) IN COMPLEX WITH COMPOUND 1 (N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2'- TITLE 3 (2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL] METHYL}-3,4- TITLE 4 DIHYDROQUINAZOLIN-6-YL)THIOPHENE-2-CARBOXAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHIMERA PROTEIN OF TYPE-2 ANGIOTENSIN II RECEPTOR AND COMPND 3 SOLUBLE CYTOCHROME B562; COMPND 4 CHAIN: B; COMPND 5 FRAGMENT: UNP P0ABE7 RESIDUES 23-128 AND UNP P50052 35-335 LINKED VIA COMPND 6 LINKER RESDIUES GSGS; COMPND 7 SYNONYM: CYTOCHROME B-562,ANGIOTENSIN II TYPE-2 RECEPTOR,AT2; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 562, 9606; SOURCE 5 GENE: CYBC, AGTR2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9 KEYWDS HUMAN ANGIOTENSIN II RECEPTOR COMPLEX, GPCR SIGNALING, GPCR, BRIL, KEYWDS 2 MEMBRANE PROTEIN, LCP, XFEL, BLOOD PRESSURE REGULATION, ORTHORHOMBIC KEYWDS 3 CRYSTAL, COMPOUND 1 (CPD 1), SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR H.ZHANG,G.W.HAN,A.BATYUK,A.ISHCHENKO,K.L.WHITE,N.PATEL,A.SADYBEKOV, AUTHOR 2 B.ZAMLYNNY,M.T.RUDD,K.HOLLENSTEIN,A.TOLSTIKOVA,T.A.WHITE,M.S.HUNTER, AUTHOR 3 U.WEIERSTALL,W.LIU,K.BABAOGLU,E.L.MOORE,R.D.KATZ,J.M.SHIPMAN, AUTHOR 4 M.GARCIA-CALVO,S.SHARMA,P.SHETH,S.M.SOISSON,R.C.STEVENS,V.KATRITCH, AUTHOR 5 V.CHEREZOV REVDAT 3 28-NOV-18 5UNG 1 REMARK REVDAT 2 10-MAY-17 5UNG 1 JRNL REMARK REVDAT 1 05-APR-17 5UNG 0 JRNL AUTH H.ZHANG,G.W.HAN,A.BATYUK,A.ISHCHENKO,K.L.WHITE,N.PATEL, JRNL AUTH 2 A.SADYBEKOV,B.ZAMLYNNY,M.T.RUDD,K.HOLLENSTEIN,A.TOLSTIKOVA, JRNL AUTH 3 T.A.WHITE,M.S.HUNTER,U.WEIERSTALL,W.LIU,K.BABAOGLU, JRNL AUTH 4 E.L.MOORE,R.D.KATZ,J.M.SHIPMAN,M.GARCIA-CALVO,S.SHARMA, JRNL AUTH 5 P.SHETH,S.M.SOISSON,R.C.STEVENS,V.KATRITCH,V.CHEREZOV JRNL TITL STRUCTURAL BASIS FOR SELECTIVITY AND DIVERSITY IN JRNL TITL 2 ANGIOTENSIN II RECEPTORS. JRNL REF NATURE V. 544 327 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28379944 JRNL DOI 10.1038/NATURE22035 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 13269 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.241 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.210 REMARK 3 FREE R VALUE TEST SET COUNT : 691 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2693 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2400 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2544 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE : 0.2630 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.53 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 149 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3195 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 1 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 80.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 82.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.17680 REMARK 3 B22 (A**2) : 4.93740 REMARK 3 B33 (A**2) : -2.76060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.490 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 2.894 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.357 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 2.685 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.363 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3351 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4557 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1105 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 61 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 483 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3351 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 441 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3803 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 0.92 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 1.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.37 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { B| 1001 - 1110 } REMARK 3 ORIGIN FOR THE GROUP (A): 22.6292 36.8452 -13.5705 REMARK 3 T TENSOR REMARK 3 T11: -0.0262 T22: -0.1488 REMARK 3 T33: -0.0310 T12: -0.0029 REMARK 3 T13: 0.0075 T23: -0.0382 REMARK 3 L TENSOR REMARK 3 L11: 1.3494 L22: 2.9298 REMARK 3 L33: 3.5237 L12: 0.7639 REMARK 3 L13: 1.7428 L23: -0.3012 REMARK 3 S TENSOR REMARK 3 S11: -0.0137 S12: 0.0173 S13: -0.0525 REMARK 3 S21: -0.0295 S22: 0.0197 S23: 0.1097 REMARK 3 S31: -0.0332 S32: 0.0294 S33: -0.0061 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B| 35 - 334 } REMARK 3 ORIGIN FOR THE GROUP (A): 9.7938 -1.6740 -19.1740 REMARK 3 T TENSOR REMARK 3 T11: -0.2334 T22: -0.2102 REMARK 3 T33: -0.0545 T12: -0.0055 REMARK 3 T13: -0.0540 T23: 0.0207 REMARK 3 L TENSOR REMARK 3 L11: 1.3717 L22: 3.2587 REMARK 3 L33: 1.9040 L12: 0.6911 REMARK 3 L13: 0.0630 L23: 0.0219 REMARK 3 S TENSOR REMARK 3 S11: 0.0973 S12: -0.1024 S13: 0.0360 REMARK 3 S21: 0.2630 S22: 0.0820 S23: 0.0795 REMARK 3 S31: 0.0691 S32: -0.1515 S33: -0.1793 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5UNG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-17. REMARK 100 THE DEPOSITION ID IS D_1000226079. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 294 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : CXI REMARK 200 X-RAY GENERATOR MODEL : SLAC LCLS BEAMLINE CXI REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.3 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : K-B MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : CS-PAD CXI-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTFEL REMARK 200 DATA SCALING SOFTWARE : CRYSTFEL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13330 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 28.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 85.50 REMARK 200 R MERGE (I) : 0.14800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 27.20 REMARK 200 R MERGE FOR SHELL (I) : 1.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4YAY, 4ZUD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM TRIS-HCL, PH 8.0, 25 MM REMARK 280 POTASSIUM FORMATE, 25% (V/V) PEG400, AND 0.3% (V/V) (+/-)-2- REMARK 280 METHYL-2,4-PENTANEDIOL, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.70500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.13000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 46.70500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL B 335 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B1042 CE NZ REMARK 470 SER B 36 OG REMARK 470 LYS B 38 CG CD CE NZ REMARK 470 ASP B 41 CG OD1 OD2 REMARK 470 HIS B 43 CG ND1 CD2 CE1 NE2 REMARK 470 LEU B 44 CG CD1 CD2 REMARK 470 GLN B 72 CG CD OE1 NE2 REMARK 470 LYS B 77 CG CD CE NZ REMARK 470 ARG B 154 CD NE CZ NH1 NH2 REMARK 470 ARG B 155 CZ NH1 NH2 REMARK 470 TRP B 158 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 158 CZ3 CH2 REMARK 470 GLU B 188 CG CD OE1 OE2 REMARK 470 THR B 241 OG1 CG2 REMARK 470 GLN B 326 CG CD OE1 NE2 REMARK 470 ARG B 330 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 333 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG B 334 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN B 72 -10.03 -153.37 REMARK 500 LYS B 73 -62.72 -133.55 REMARK 500 LYS B 77 142.35 70.76 REMARK 500 LEU B 111 43.75 -106.71 REMARK 500 PRO B 157 59.27 -94.07 REMARK 500 PHE B 220 -51.38 -140.15 REMARK 500 ASN B 242 71.61 56.83 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLC B 1202 REMARK 610 OLA B 1203 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8ES B 1201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLC B 1202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5UNF RELATED DB: PDB REMARK 900 RELATED ID: 5UNH RELATED DB: PDB DBREF 5UNG B 1001 1106 UNP P0ABE7 C562_ECOLX 23 128 DBREF 5UNG B 35 335 UNP P50052 AGTR2_HUMAN 35 335 SEQADV 5UNG TRP B 1007 UNP P0ABE7 MET 29 ENGINEERED MUTATION SEQADV 5UNG ILE B 1102 UNP P0ABE7 HIS 124 ENGINEERED MUTATION SEQADV 5UNG LEU B 1106 UNP P0ABE7 ARG 128 ENGINEERED MUTATION SEQADV 5UNG GLY B 1107 UNP P0ABE7 LINKER SEQADV 5UNG SER B 1108 UNP P0ABE7 LINKER SEQADV 5UNG GLY B 1109 UNP P0ABE7 LINKER SEQADV 5UNG SER B 1110 UNP P0ABE7 LINKER SEQRES 1 B 411 ALA ASP LEU GLU ASP ASN TRP GLU THR LEU ASN ASP ASN SEQRES 2 B 411 LEU LYS VAL ILE GLU LYS ALA ASP ASN ALA ALA GLN VAL SEQRES 3 B 411 LYS ASP ALA LEU THR LYS MET ARG ALA ALA ALA LEU ASP SEQRES 4 B 411 ALA GLN LYS ALA THR PRO PRO LYS LEU GLU ASP LYS SER SEQRES 5 B 411 PRO ASP SER PRO GLU MET LYS ASP PHE ARG HIS GLY PHE SEQRES 6 B 411 ASP ILE LEU VAL GLY GLN ILE ASP ASP ALA LEU LYS LEU SEQRES 7 B 411 ALA ASN GLU GLY LYS VAL LYS GLU ALA GLN ALA ALA ALA SEQRES 8 B 411 GLU GLN LEU LYS THR THR ARG ASN ALA TYR ILE GLN LYS SEQRES 9 B 411 TYR LEU GLY SER GLY SER CYS SER GLN LYS PRO SER ASP SEQRES 10 B 411 LYS HIS LEU ASP ALA ILE PRO ILE LEU TYR TYR ILE ILE SEQRES 11 B 411 PHE VAL ILE GLY PHE LEU VAL ASN ILE VAL VAL VAL THR SEQRES 12 B 411 LEU PHE CYS CYS GLN LYS GLY PRO LYS LYS VAL SER SER SEQRES 13 B 411 ILE TYR ILE PHE ASN LEU ALA VAL ALA ASP LEU LEU LEU SEQRES 14 B 411 LEU ALA THR LEU PRO LEU TRP ALA THR TYR TYR SER TYR SEQRES 15 B 411 ARG TYR ASP TRP LEU PHE GLY PRO VAL MET CYS LYS VAL SEQRES 16 B 411 PHE GLY SER PHE LEU THR LEU ASN MET PHE ALA SER ILE SEQRES 17 B 411 PHE PHE ILE THR CYS MET SER VAL ASP ARG TYR GLN SER SEQRES 18 B 411 VAL ILE TYR PRO PHE LEU SER GLN ARG ARG ASN PRO TRP SEQRES 19 B 411 GLN ALA SER TYR ILE VAL PRO LEU VAL TRP CYS MET ALA SEQRES 20 B 411 CYS LEU SER SER LEU PRO THR PHE TYR PHE ARG ASP VAL SEQRES 21 B 411 ARG THR ILE GLU TYR LEU GLY VAL ASN ALA CYS ILE MET SEQRES 22 B 411 ALA PHE PRO PRO GLU LYS TYR ALA GLN TRP SER ALA GLY SEQRES 23 B 411 ILE ALA LEU MET LYS ASN ILE LEU GLY PHE ILE ILE PRO SEQRES 24 B 411 LEU ILE PHE ILE ALA THR CYS TYR PHE GLY ILE ARG LYS SEQRES 25 B 411 HIS LEU LEU LYS THR ASN SER TYR GLY LYS ASN ARG ILE SEQRES 26 B 411 THR ARG ASP GLN VAL LEU LYS MET ALA ALA ALA VAL VAL SEQRES 27 B 411 LEU ALA PHE ILE ILE CYS TRP LEU PRO PHE HIS VAL LEU SEQRES 28 B 411 THR PHE LEU ASP ALA LEU ALA TRP MET GLY VAL ILE ASN SEQRES 29 B 411 SER CYS GLU VAL ILE ALA VAL ILE ASP LEU ALA LEU PRO SEQRES 30 B 411 PHE ALA ILE LEU LEU GLY PHE THR ASN SER CYS VAL ASN SEQRES 31 B 411 PRO PHE LEU TYR CYS PHE VAL GLY ASN ARG PHE GLN GLN SEQRES 32 B 411 LYS LEU ARG SER VAL PHE ARG VAL HET 8ES B1201 46 HET OLC B1202 14 HET OLA B1203 10 HETNAM 8ES N-BENZYL-N-(2-ETHYL-4-OXO-3-{[2'-(2H-TETRAZOL-5-YL)[1, HETNAM 2 8ES 1'-BIPHENYL]-4-YL]METHYL}-3,4-DIHYDROQUINAZOLIN-6-YL) HETNAM 3 8ES THIOPHENE-2-CARBOXAMIDE HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM OLA OLEIC ACID HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 8ES C36 H29 N7 O2 S FORMUL 3 OLC C21 H40 O4 FORMUL 4 OLA C18 H34 O2 FORMUL 5 HOH *(H2 O) HELIX 1 AA1 ASP B 1002 ALA B 1020 1 19 HELIX 2 AA2 ASN B 1022 ALA B 1043 1 22 HELIX 3 AA3 SER B 1055 GLU B 1081 1 27 HELIX 4 AA4 LYS B 1083 ALA B 1091 1 9 HELIX 5 AA5 GLN B 1093 TYR B 1105 1 13 HELIX 6 AA6 ASP B 45 GLN B 72 1 28 HELIX 7 AA7 LYS B 77 ALA B 95 1 19 HELIX 8 AA8 THR B 96 TYR B 106 1 11 HELIX 9 AA9 GLY B 113 TYR B 148 1 36 HELIX 10 AB1 PRO B 149 SER B 152 5 4 HELIX 11 AB2 GLN B 159 SER B 175 1 17 HELIX 12 AB3 SER B 175 PHE B 181 1 7 HELIX 13 AB4 PRO B 200 GLU B 202 5 3 HELIX 14 AB5 LYS B 203 PHE B 220 1 18 HELIX 15 AB6 PHE B 220 LYS B 240 1 21 HELIX 16 AB7 GLY B 245 GLY B 285 1 41 HELIX 17 AB8 SER B 289 CYS B 319 1 31 HELIX 18 AB9 PHE B 320 ASN B 323 5 4 HELIX 19 AC1 ARG B 324 ARG B 334 1 11 SHEET 1 AA1 2 ARG B 182 ILE B 187 0 SHEET 2 AA1 2 VAL B 192 MET B 197 -1 O VAL B 192 N ILE B 187 SSBOND 1 CYS B 35 CYS B 290 1555 1555 2.04 SSBOND 2 CYS B 117 CYS B 195 1555 1555 2.03 SITE 1 AC1 14 TYR B 51 TRP B 100 TYR B 103 LEU B 124 SITE 2 AC1 14 THR B 125 MET B 128 PHE B 129 THR B 178 SITE 3 AC1 14 ARG B 182 LYS B 215 TRP B 269 PHE B 272 SITE 4 AC1 14 ILE B 304 PHE B 308 SITE 1 AC2 6 PRO B 48 TYR B 52 THR B 102 SER B 105 SITE 2 AC2 6 ALA B 228 THR B 229 CRYST1 70.260 78.790 93.410 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014233 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012692 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010705 0.00000 MASTER 326 0 3 19 2 0 6 6 0 0 0 32 END